Risk of Infection Associated With Administration of Intravenous Iron
暂无分享,去创建一个
S. Brunskill | S. Stanworth | E. Litton | A. Palmer | A. Acheson | E. Dickson | A. Sugavanam | K. Donovan | J. Reid | C. Dorée | A. Shah | Claire Seeley
[1] M. Tanner,et al. Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial. , 2020, The Lancet. Global health.
[2] P. Ponikowski,et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial , 2020, The Lancet.
[3] Karolina Kaluza,et al. Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications , 2020, Current medical research and opinion.
[4] L. Miles. The end of the beginning: pre‐operative intravenous iron and the PREVENTT trial , 2020, Anaesthesia.
[5] J. Browne,et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial , 2020, The Lancet.
[6] B. Lämmle,et al. The effects of intravenous iron supplementation on fatigue and general health in non-anemic blood donors with iron deficiency: a randomized placebo-controlled superiority trial , 2020, Scientific Reports.
[7] Rafael Bielza,et al. Effect of intravenous iron on functional outcomes in hip fracture: a randomised controlled trial. , 2020, Age and ageing.
[8] D. Sessler,et al. Prospective observational study of postoperative infection and outcomes after noncardiac surgery: analysis of prospective data from the VISION cohort. , 2020, British journal of anaesthesia.
[9] S. Pearson,et al. Rapid increase in intravenous iron therapy for women of reproductive age in Australia , 2020, The Medical journal of Australia.
[10] H. de Boer,et al. A randomized controlled trial comparing oral and intravenous iron supplementation after Roux-en-Y gastric bypass surgery. , 2020, Clinical nutrition.
[11] W. Winkelmayer,et al. Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk , 2020, Kidney medicine.
[12] T. Pieber,et al. High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. , 2020, Clinical nutrition.
[13] S. Zodpey,et al. Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial. , 2019, The Lancet. Global health.
[14] Xin Yuan,et al. Intravenous Iron Versus Placebo in the Management of Postoperative Functional Iron Deficiency Anemia in Patients Undergoing Cardiac Valvular Surgery: A Prospective, Single-Blinded, Randomized Controlled Trial. , 2019, Journal of cardiothoracic and vascular anesthesia.
[15] Tae-Yop Kim,et al. The Effect of Intraoperative Ferric Carboxymaltose in Joint Arthroplasty Patients: A Randomized Trial , 2019, Journal of clinical medicine.
[16] Luis Ferrer-Barceló,et al. Randomised clinical trial: intravenous vs oral iron for the treatment of anaemia after acute gastrointestinal bleeding , 2019, Alimentary pharmacology & therapeutics.
[17] B. Seifert,et al. Effect of ultra-short-term treatment of patients with iron deficiency or anaemia undergoing cardiac surgery: a prospective randomised trial , 2019, The Lancet.
[18] S. Brunskill,et al. Risk of infection associated with intravenous iron preparations: protocol for updating a systematic review , 2019, BMJ Open.
[19] O. Sahota,et al. The effect of intravenous iron on erythropoiesis in older people with hip fracture. , 2019, Age and ageing.
[20] G. Kemp,et al. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency. , 2019, Circulation.
[21] Christopher L. Wu,et al. Systematic review and consensus definitions for the Standardised Endpoints in Perioperative Medicine (StEP) initiative: infection and sepsis , 2019, British journal of anaesthesia.
[22] E. Wood,et al. Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference , 2019, JAMA.
[23] E. Litton,et al. Iron Metabolism: An Emerging Therapeutic Target in Critical Illness , 2019, Critical Care.
[24] A. Darwish,et al. RETRACTED ARTICLE: Total dose iron dextran infusion versus oral iron for treating iron deficiency anemia in pregnant women: a randomized controlled trial , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[25] J. McMurray,et al. Intravenous Iron in Patients Undergoing Maintenance Hemodialysis , 2019, The New England journal of medicine.
[26] R. Porcher,et al. Iron deficiency and infection: another pathway to explore in critically ill patients? , 2018, Intensive Care Medicine.
[27] J. Allen,et al. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. , 2018, Seminars in hematology.
[28] C. Bokemeyer,et al. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines† , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] X. Capdevila,et al. Preoperative Epoetin-&agr; with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial , 2018, Anesthesiology.
[30] S. Madhusudan,et al. Feasibility of Intravenous Iron Isomaltoside to Improve Anemia and Quality of Life During Palliative Chemotherapy for Esophagogastric Adenocarcinoma , 2018, Nutrition and cancer.
[31] Hiroaki Ito,et al. Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study , 2018, International Journal of Hematology.
[32] A. Nevill,et al. Intravenous iron does not effectively correct preoperative anaemia in cardiac surgery: a pilot randomized controlled trial. , 2018, Interactive cardiovascular and thoracic surgery.
[33] A. Prentice,et al. Reducing anaemia in low income countries: control of infection is essential , 2018, British Medical Journal.
[34] H. Kehlet,et al. An international consensus statement on the management of postoperative anaemia after major surgical procedures , 2018, Anaesthesia.
[35] Élvio Bueno Garcia,et al. Intravenous iron sucrose versus oral iron administration for the postoperative treatment of post-bariatric abdominoplasty anaemia: an open-label, randomised, superiority trial in Brazil. , 2018, The Lancet. Haematology.
[36] C. Boomershine,et al. A Blinded, Randomized, Placebo-Controlled Study to Investigate the Efficacy and Safety of Ferric Carboxymaltose in Iron-Deficient Patients with Fibromyalgia , 2018, Rheumatology and Therapy.
[37] K. Prabhash,et al. Phase III randomized trial comparing intravenous to oral iron in patients with cancer‐related iron deficiency anemia not on erythropoiesis stimulating agents , 2018, Asia-Pacific journal of clinical oncology.
[38] H. Kim,et al. Postoperative Intravenous Ferric Carboxymaltose Reduces Transfusion Amounts after Orthopedic Hip Surgery , 2018, Clinics in orthopedic surgery.
[39] Ruili Li,et al. Single‐dose intravenous iron in Southeast Asian heart failure patients: A pilot randomized placebo‐controlled study (PRACTICE‐ASIA‐HF) , 2018, ESC heart failure.
[40] P. Meybohm,et al. Post-Operative Iron Carboxymaltose May Have an Effect on Haemoglobin Levels in Cardiothoracic Surgical Patients on the ICU - an Observational Pilot Study about Anaemia Treatment with Intravenous Iron , 2018, Transfusion Medicine and Hemotherapy.
[41] Y. Cho,et al. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome. , 2017, Sleep medicine.
[42] P. Ponikowski,et al. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Chronic Heart Failure and Iron Deficiency , 2017, Circulation.
[43] S. Spitalnik,et al. Iron: a double‐edged sword , 2017, Transfusion.
[44] C. Natanson,et al. Parenteral irons versus transfused red blood cells for treatment of anemia during canine experimental bacterial pneumonia , 2017, Transfusion.
[45] K. Itani,et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 , 2017, JAMA surgery.
[46] W. Oertel,et al. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial , 2017, Movement disorders : official journal of the Movement Disorder Society.
[47] N. Milman,et al. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP) , 2017, Journal of perinatal medicine.
[48] Young-Woo Kim,et al. Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response Among Patients With Acute Isovolemic Anemia Following Gastrectomy: The FAIRY Randomized Clinical Trial , 2017, JAMA.
[49] P. Jaju,et al. Intravenous iron sucrose v/s oral ferrous fumarate for treatment of anemia in pregnancy. A randomized controlled trial , 2017, BMC Pregnancy and Childbirth.
[50] A. Chatwani,et al. Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency Anemia , 2017, Anemia.
[51] N. I. Khouly. Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia , 2017 .
[52] J. Langhoff‐Roos,et al. Single‐dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial , 2017, Vox sanguinis.
[53] Q. Jia,et al. Efficacy of Intravenous Iron Sucrose in Hemodialysis Patients with Restless Legs Syndrome (RLS): A Randomized, Placebo-Controlled Study , 2017, Medical science monitor : international medical journal of experimental and clinical research.
[54] M. Brookes,et al. Randomized clinical trial of preoperative oral versus intravenous iron in anaemic patients with colorectal cancer , 2017, The British journal of surgery.
[55] H. Kehlet,et al. International consensus statement on the peri‐operative management of anaemia and iron deficiency , 2017, Anaesthesia.
[56] T. Deloughery,et al. Single-dose intravenous iron for iron deficiency: a new paradigm. , 2016, Hematology. American Society of Hematology. Education Program.
[57] Suchitra Thunga,et al. IV Ferric Carboxymaltose Vs Oral Iron in the Treatment of Post-partum Iron Deficiency Anaemia. , 2016, Journal of clinical and diagnostic research : JCDR.
[58] M. Hernán,et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.
[59] T. Richards,et al. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial , 2016, Intensive Care Medicine.
[60] M. Bernabeu-Wittel,et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial , 2016, Transfusion.
[61] Y. Cho,et al. Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome. , 2016, Sleep medicine.
[62] I. Robertson,et al. Intravenous ferric carboxymaltose versus standard care in the management of postoperative anaemia: a prospective, open-label, randomised controlled trial. , 2016, The Lancet. Haematology.
[63] Volkmar Falk,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[64] G. Birgegard,et al. A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial , 2016, Pharmacotherapy.
[65] Christopher W Seymour,et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[66] Rajvinder Singh,et al. The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery , 2016, Annals of surgery.
[67] S. Bonovas,et al. Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease , 2016, Medicine.
[68] Mark S Levenson,et al. Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products. , 2015, JAMA.
[69] Ben J. Marafino,et al. Receipt of Intravenous Iron and Clinical Outcomes among Hemodialysis Patients Hospitalized for Infection. , 2015, Clinical journal of the American Society of Nephrology : CJASN.
[70] P. Kalra,et al. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[71] T. Richards,et al. Effect of Intravenous Iron on Aerobic Capacity and Iron Metabolism in Elite Athletes. , 2015, Medicine and science in sports and exercise.
[72] J. Kusek,et al. A randomized trial of intravenous and oral iron in chronic kidney disease , 2015, Kidney international.
[73] L. Thomsen,et al. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial) , 2015, Vox sanguinis.
[74] F. Kronenberg,et al. Iron Supplementation and Mortality in Incident Dialysis Patients: An Observational Study , 2014, PloS one.
[75] Sunil V. Rao,et al. A prospective randomized wait list control trial of intravenous iron sucrose in older adults with unexplained anemia and serum ferritin 20-200 ng/mL. , 2014, Blood cells, molecules & diseases.
[76] G. Birgegard,et al. Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy , 2014, Medical Oncology.
[77] T. Kuragano,et al. Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients. , 2014, Kidney international.
[78] K. Thompson,et al. Four Weeks of IV Iron Supplementation Reduces Perceived Fatigue and Mood Disturbance in Distance Runners , 2014, PloS one.
[79] E. Bisbe,et al. Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty. , 2014, British journal of anaesthesia.
[80] E. Moore,et al. A Multicenter, Randomized Clinical Trial of IV Iron Supplementation for Anemia of Traumatic Critical Illness* , 2014, Critical care medicine.
[81] P. Ponikowski,et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency† , 2014, European heart journal.
[82] I. Macdougall,et al. FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[83] Avantika Gupta,et al. A Randomised Controlled Trial to Compare Intravenous Iron Sucrose and Oral Iron in Treatment of Iron Deficiency Anemia in Pregnancy , 2014, Indian Journal of Hematology and Blood Transfusion.
[84] H. Sagili,et al. Intravenous iron sucrose and oral iron for the treatment of iron deficiency anaemia in pregnancy. , 2014, Journal of clinical and diagnostic research : JCDR.
[85] M. Palacio,et al. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial , 2014, BJOG : an international journal of obstetrics and gynaecology.
[86] W. Winkelmayer,et al. Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). , 2014, JAMA internal medicine.
[87] J. Dahlerup,et al. Randomised clinical trial: oral vs. intravenous iron after upper gastrointestinal haemorrhage – a placebo‐controlled study , 2014, Alimentary pharmacology & therapeutics.
[88] Carol A. Keohane,et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. , 2013, JAMA internal medicine.
[89] T. Manchana,et al. Prevention of blood transfusion with intravenous iron in gynecologic cancer patients receiving platinum-based chemotherapy. , 2013, Gynecologic oncology.
[90] F. Baron,et al. Darbepoetin‐alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: A prospective multicenter randomized trial , 2013, American journal of hematology.
[91] W. Reinisch,et al. A Randomized, Open-Label, Non-Inferiority Study of Intravenous Iron Isomaltoside 1,000 (Monofer) Compared With Oral Iron for Treatment of Anemia in IBD (PROCEED) , 2013, The American Journal of Gastroenterology.
[92] L. Rohde,et al. IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia. , 2013, International journal of cardiology.
[93] T. Ganz. Systemic iron homeostasis. , 2013, Physiological reviews.
[94] David C. Ford,et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron , 2013, American journal of hematology.
[95] K. Ho,et al. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials , 2013, BMJ.
[96] A. Makhlough,et al. Comparative Study of Intravenous Iron Versus Intravenous Ascorbic Acid for Treatment of Functional Iron Deficiency in Patients Under Hemodialysis: A Randomized Clinical Trial , 2013, Nephro-urology monthly.
[97] W. Reinisch,et al. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[98] T. Waldhör,et al. Iron Deficiency Generates Secondary Thrombocytosis and Platelet Activation in IBD: the Randomized, Controlled ThromboVIT Trial , 2013, Inflammatory bowel diseases.
[99] R. Harrington,et al. A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia , 2013, Transfusion.
[100] Eric P. Skaar,et al. Iron in infection and immunity. , 2013, Cell host & microbe.
[101] N. Hodyl,et al. Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial , 2013, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[102] S. Jha,et al. Intravenous Iron in Postpartum Anemia , 2013, The Journal of Obstetrics and Gynecology of India.
[103] J. Cuenca,et al. Very‐short‐term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients , 2013, Transfusion.
[104] R. Testa,et al. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[105] P. Marteau,et al. Ferric carboxymaltose prevents recurrence of anemia in patients with inflammatory bowel disease. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[106] P. Ghosh,et al. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: A randomized clinical trial , 2013, The journal of obstetrics and gynaecology research.
[107] S. Leichtle,et al. Construct domain analysis of patient health-related quality of life: physical and mental trajectory profiles following open versus endovascular repair of abdominal aortic aneurysm , 2012, Patient related outcome measures.
[108] A. Jiménez-Sosa,et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial. , 2012, Interactive cardiovascular and thoracic surgery.
[109] A. Prentice,et al. Hepcidin and the Iron-Infection Axis , 2012, Science.
[110] L. Rai,et al. Iron Sucrose Versus Oral Iron Therapy in Pregnancy Anemia , 2012, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine.
[111] D. Bregman,et al. Safety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials , 2012, Anemia.
[112] A. Sathe,et al. Iron Deficiency Anemia in Pregnancy: Intravenous Versus Oral Route , 2012, The Journal of Obstetrics and Gynecology of India.
[113] David W. Johnson,et al. A Randomized Controlled Trial of Intravenous or Oral Iron for Posttransplant Anemia in Kidney Transplantation , 2012, Transplantation.
[114] Y. Yoo,et al. Effect of Single Recombinant Human Erythropoietin Injection on Transfusion Requirements in Preoperatively Anemic Patients Undergoing Valvular Heart Surgery , 2011, Anesthesiology.
[115] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[116] C. Adler,et al. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. , 2011, Sleep medicine.
[117] E. Battegay,et al. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. , 2011, Blood.
[118] N. Malhotra,et al. Intravenous Iron Therapy versus Oral Iron in Postpartum Patients in Rural Area , 2011 .
[119] L. Adhikary,et al. Efficacy of IV iron compared to oral iron for increment of haemoglobin level in anemic chronic kidney disease patients on erythropoietin therapy. , 2011, JNMA; journal of the Nepal Medical Association.
[120] R. Shrivastava,et al. Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease , 2011, Nephron Clinical Practice.
[121] P. C. Benítez,et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single‐center randomized controlled trial , 2011, Transfusion.
[122] C. Kim,et al. Effects of intravenous iron combined with low‐dose recombinant human erythropoietin on transfusion requirements in iron‐deficient patients undergoing bilateral total knee replacement arthroplasty (CME) , 2011, Transfusion.
[123] G. Birgegard,et al. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron , 2010, Vox sanguinis.
[124] A. Mangione,et al. A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[125] T. Ciuleanu,et al. Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia , 2010, American journal of hematology.
[126] J. Rasko,et al. A prospective randomized, controlled trial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy , 2010, Journal of internal medicine.
[127] G. Mantovani,et al. Efficacy and safety of oral lactoferrin supplementation in combination with rHuEPO-beta for the treatment of anemia in advanced cancer patients undergoing chemotherapy: open-label, randomized controlled study. , 2010, The oncologist.
[128] P. Kerr,et al. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[129] Penkae Dangsuwan,et al. Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy. , 2010, Gynecologic oncology.
[130] G. Bailie,et al. Safety and tolerability of intravenous ferric carboxymaltose in patients with iron deficiency anemia , 2010, Hemodialysis international. International Symposium on Home Hemodialysis.
[131] P. Ponikowski,et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.
[132] T. J. Edwards,et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery , 2009, The British journal of surgery.
[133] A. Mangione,et al. BLOOD MANAGEMENT: Large‐dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial , 2009, Transfusion.
[134] R. Zimmermann,et al. Iron prophylaxis in pregnancy: intravenous route versus oral route. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[135] H. Chung,et al. Safety and Usefulness of Intravenous Iron Sucrose in the Management of Preoperative Anemia in Patients with Menorrhagia: A Phase IV, Open-Label, Prospective, Randomized Study , 2009, Acta Haematologica.
[136] B. Pereira,et al. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[137] S. Lindgren,et al. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study , 2009, Scandinavian journal of gastroenterology.
[138] D. Tarng,et al. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. , 2008, Journal of the American Society of Nephrology : JASN.
[139] K. Salvesen,et al. A 12‐week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia , 2008, Acta obstetricia et gynecologica Scandinavica.
[140] A. Kausz,et al. Ferumoxytol for treating iron deficiency anemia in CKD. , 2008, Journal of the American Society of Nephrology : JASN.
[141] C. Breymann,et al. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[142] T. Pintér,et al. Randomized, multicenter, controlled trial comparing the efficacy and safety of darbepoetin alpha administered every 3 weeks with or without intravenous iron in patients with chemotherapy-induced anemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[143] R. Labianca,et al. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[144] G. D'Haens,et al. A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial , 2008, The American Journal of Gastroenterology.
[145] Shixiang Wang,et al. Intravenous Iron Sucrose in Peritoneal Dialysis Patients with Renal Anemia , 2008, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[146] P. Ponikowski,et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2008, Journal of the American College of Cardiology.
[147] Y. Yazdanpanah,et al. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis , 2007, Gut.
[148] P. Duarte,et al. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.
[149] A. Mangione,et al. Intravenous Ferric Carboxymaltose Compared With Oral Iron in the Treatment of Postpartum Anemia: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.
[150] G. Birgegard,et al. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study , 2007, Leukemia.
[151] Jae Hoon Kim,et al. Effect of intravenously administered iron sucrose on the prevention of anemia in the cervical cancer patients treated with concurrent chemoradiotherapy. , 2007, Gynecologic oncology.
[152] Ajay K. Singh,et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) Study. , 2007, Journal of the American Society of Nephrology : JASN.
[153] N. Dahl,et al. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy. , 2007, The oncologist.
[154] A. Besarab,et al. A Randomized Controlled Trial of Oral versus Intravenous Iron in Chronic Kidney Disease , 2006, American Journal of Nephrology.
[155] N. Bhandal,et al. Intravenous versus oral iron therapy for postpartum anaemia , 2006, BJOG : an international journal of obstetrics and gynaecology.
[156] J. Cangiano,et al. Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. , 2006, Clinical journal of the American Society of Nephrology : CJASN.
[157] A. Prentice,et al. Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. , 2006, Clinical science.
[158] D. V. Van Wyck,et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. , 2005, Kidney international.
[159] O. Kandemir,et al. Intravenous Versus Oral Iron for Treatment of Anemia in Pregnancy: A Randomized Trial , 2005, Obstetrics and gynecology.
[160] S. Schreiber,et al. Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease—A Randomized, Controlled, Open-Label, Multicenter Study , 2005, The American Journal of Gastroenterology.
[161] G. Bailie,et al. Comparison of Intravenous Iron Sucrose to Oral Iron in the Treatment of Anemic Patients with Chronic Kidney Disease Not on Dialysis , 2005, Nephron Clinical Practice.
[162] N. Demartines,et al. Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of surgery.
[163] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[164] A. Kausz,et al. Iron therapy in the pediatric hemodialysis population , 2004, Pediatric Nephrology.
[165] A. Feigin,et al. A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[166] M. Auerbach,et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[167] A. Yazigi,et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery. , 2004, Journal of cardiothoracic and vascular anesthesia.
[168] M. Müllner,et al. High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity. , 2003, Kidney international.
[169] Hemant,et al. Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin. , 2003, The Journal of the Association of Physicians of India.
[170] A. Nissenson,et al. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. , 2002, Kidney international.
[171] M. Laxenaire,et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. , 2002, American journal of obstetrics and gynecology.
[172] L. Nogarin,et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo‐controlled trial , 2001, Transfusion.
[173] A. van de Wiel,et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients , 2000, Critical care medicine.
[174] G. Lauer,et al. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study , 1999, Transfusion.
[175] M. Klimek,et al. Efficacy of oral iron supplementation is not enhanced by additional intravenous iron during autologous blood donation , 1998, Transfusion.
[176] P. Kuperan,et al. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann®) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy , 1998, European journal of haematology.
[177] A. Al-Meshari,et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. , 1996, European journal of obstetrics, gynecology, and reproductive biology.
[178] I. Macdougall,et al. A randomized controlled study of iron supplementation in patients treated with erythropoietin. , 1996, Kidney international.
[179] M. Meyer,et al. A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. , 1996, The Journal of pediatrics.
[180] B. Bistrian,et al. Effect of iron-supplemented total parenteral nutrition in patients with iron deficiency anemia. , 1996, Nutrition.
[181] S. Fishbane,et al. The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients. , 1995, Clinical nephrology.
[182] J. Friel,et al. Intravenous iron administration to very-low-birth-weight newborns receiving total and partial parenteral nutrition. , 1995, JPEN. Journal of parenteral and enteral nutrition.
[183] J M Hughes,et al. CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.
[184] Shikha Madan,et al. Oral Versus Intravenous Iron for Treatment of Iron Deficiency Anaemia in Pregnancy: A Randomized Controlled Trial , 2018 .
[185] K. Kavitha,et al. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital , 2017 .
[186] M. Azam,et al. Comparison between Intravenous Iron and Oral Iron Therapy in Cases of Postpartum Anemia , 2017 .
[187] Assem A. M. Elbiaa,et al. Heme iron polypeptide (proferrin®-ES) versus iron saccharate complex (ferrosac) for treatment of iron deficiency anemia during pregnancy , 2017 .
[188] J. Nath,et al. Comparison of intravenous iron sucrose with oral iron in pregnant women with iron deficiency anaemia , 2016 .
[189] L. Leibovici,et al. The safety of intravenous iron preparations: systematic review and meta-analysis. , 2015, Mayo Clinic proceedings.
[190] N. Pescosolido. Therapeutics and clinical risk management , 2015 .
[191] S. Samal,et al. Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women , 2015, International journal of applied & basic medical research.
[192] E. Martín-Montañez,et al. Cost of post-operative intravenous iron therapy in total lower limb arthroplasty: a retrospective, matched cohort study. , 2014, Blood transfusion = Trasfusione del sangue.
[193] V. Suri,et al. Is it safe to use intravenous iron sucrose during pregnancy? A randomized controlled trial - , 2013 .
[194] P. Novotny,et al. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[195] S. Bélisle,et al. Colloids use in the perioperative setting: a canadian review , 2006 .
[196] J. Widness,et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. , 2001, Pediatrics.